Endoscopic trans-papillary biliary biopsy for genomic panel testing in cholangiocarcinoma

Endoscopic trans-papillary biliary biopsy for genomic panel testing in cholangiocarcinoma - Endoscopic trans-papillary biliary biopsy for genomic testing

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053300

Enrollment

Registered

2024-01-10

Start date

2024-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholangiocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with 20 years or older at the time of participation in the study. 2. Patients who are suspected of cholangiocarcinoma from image testing and who are planned to undergo endoscopic biliary biopsy for diagnosis.

Exclusion criteria

Exclusion criteria: 1. Patients with prothrombin time < 50% or platelet count < 50000/mm3. 2. Patients who are taking more than 2 antithrombotic drugs. 3. Patients with a history of gastrectomy other than Billroth 1. 4. Patients with gastrointestinal stenosis.

Design outcomes

Primary

Measure	Time frame
Adequacy for genomic panel testing using endoscopic bile duct biopsy	—

Countries

Japan

Contacts

Public ContactYasuhiro Kuraihsi

Shinshu university school of medicine Department of gastroenterology

yasuhiro@shinshu-u.ac.jp0263354600

Outcome results